Top in women's health: At-home menopause test; migraine, vasomotor symptoms linked to CVD
Click Here to Manage Email Alerts
A new at-home test promises the ability to indicate women’s stage in menopause, but some experts are skeptical about how useful the product actually is.
Healio spoke with several experts as well as the director of research and development at Clearblue — the manufacturer of the test — about its benefits and limitations.
It was the top story in women’s health last week.
In another top story, a study showed that women experiencing migraine and persistent vasomotor symptoms are at a higher risk for CVD and stroke.
Gina Lundberg, MD, FACC, FAHA, a preventive cardiologist at Emory School of Medicine who was uninvolved in the research, said the study “is very important” in a perspective for Healio.
“Physicians who care for women need to start thinking about CVD risks and implementing healthy lifestyle and risk reduction long before menopause,” Lundberg added.
Read these and more top stories in women’s health below:
Is an at-home menopause test useful for women? Experts weigh in
A new at-home menopause test hit the market last fall, promising women the ability to accurately measure a hormone associated with menopause stage and predict how close they might be to their final menstrual period. Read more.
Migraine plus persistent vasomotor symptoms linked to greater stroke, CVD risks
Migraine plus persistent vasomotor symptoms is associated with greater CVD risk and stroke for women, according to a secondary data analysis published in Menopause. Read more.
Bivalent HPV vaccination at age 12 to 13 years prevents cervical cancer
HPV vaccination with one or two doses at age 12 to 13 years prevents invasive cervical cancer development, researchers reported in the Journal of the National Cancer Institute. Read more.
Dexmedetomidine early after delivery reduced incidence of postpartum depression
Dexmedetomidine administration early in the postpartum period was associated with significantly lower positive postpartum depression incidence compared with placebo, researchers reported in JAMA Network Open. Read more.
Policy changes needed to improve maternal mental health in US
U.S. policy changes are needed to reduce perinatal mental health deserts, standardize social determinants of health data, improve psychiatric curriculums and establish paid parental leave, researchers reported in JAMA Psychiatry. Read more.